Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
270 results
  • Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. [Meta-Analysis]
  • JHJ Headache Pain 2016; 17(1):113
  • Xu H, Han W, … Li M
  • CONCLUSIONS: This study suggests that eletriptan may be the most suitable therapy for migraine from a comprehensive point of view. In the meantime ibuprofen may also be a good choice for its excellent tolerability. Multi-component medication also attracts attention and may be a promising avenue for the next generation of migraine treatment.
  • Menstrual Migraine and Treatment Options: Review. [Review]
  • HHeadache 2017; 57(2):194-208
  • Maasumi K, Tepper SJ, Kriegler JS
  • CONCLUSIONS: MM can be very difficult to treat. For acute treatments, rizatriptan has the best overall evidence. For short-term prevention, frovatriptan, zolmitriptan, or naratriptan, as well as magnesium, estrogen, naproxen sodium, or dihydroergotamine may be useful.
  • Formulation Approaches of Triptans for Management of Migraine. [Review]
  • CDCurr Drug Deliv 2016; 13(6):882-98
  • Kassem AA
  • CONCLUSIONS: Utilizing alternative routes for triptans' administration in addition to designing appropriate formulations, were successful approaches. However, further investigations should be conducted to establish their bioavailability and in vitro- in vivo correlation studies are also required, to confirm the potential of the designed formulations for use in humans, hence novel efficient triptans' formulations may appear on the market in the near future.
New Search Next